Neuregulins: Versatile growth and differentiation factors in nervous system development and human disease

Brain Research Reviews

Volumn 51, Issue 2, 2006, Pages 161-175

  Esper, Raymond M ^a   Pankonin, Mark S ^a   Loeb, Jeffrey A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Development; Multiple sclerosis; Neuregulin; Neurotrophic factor; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; NEUROTROPHIC FACTOR;

CLINICAL TRIAL; CYTOPLASM; DIABETIC NEUROPATHY; GLIA CELL; HUMAN; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SYNTHESIS; REVIEW; RNA SPLICING; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY; UNSPECIFIED SIDE EFFECT;

ANIMALS; BRAIN DISEASES; CELL COMMUNICATION; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; GROWTH SUBSTANCES; HUMANS; NEUREGULINS; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; SOLUBILITY;

EID: 33745155000     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2005.11.006     Document Type: Review

References (210)

1. Adlkofer K., and Lai C. Role of neuregulins in glial cell development. Glia 29 (2000) 104-111
2. Akbarian S., Sucher N.J., Bradley D., Tafazzoli A., Trinh D., Hetrick W.P., Potkin S.G., Sandman C.A., Bunney Jr. W.E., and Jones E.G. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. 16 (1996) 19-30
3. Apfel S.C. Nerve regeneration in diabetic neuropathy. Diabetes Obes. Metab. 1 (1999) 3-11
4. Apfel S.C. Neurotrophic factors in the therapy of diabetic neuropathy. Am. J. Med. 107 (1999) 34S-42S
5. Apfel S.C. Neurotrophic factor therapy-Prospects and problems. Clin. Chem. Lab. Med. 39 (2001) 351-355
6. Apfel S.C. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?. Int. Rev. Neurobiol. 50 (2002) 393-413
7. Apfel S.C., and Kessler J.A. Neurotrophic factors in the therapy of peripheral neuropathy. Bailliere's Clin. Neurol. 4 (1995) 593-606
8. Apfel S.C., and Kessler J.A. Neurotrophic factors in the treatment of peripheral neuropathy. Ciba Found. Symp. 196 (1996) 98-108 (discussion 108-112)
9. Apfel S.C., Arezzo J.C., Brownlee M., Federoff H., and Kessler J.A. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 634 (1994) 7-12
10. Apfel S.C., Kessler J.A., Adornato B.T., Litchy W.J., Sanders C., Rask C.A., and NGF Study Group. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. Neurology 51 (1998) 695-702
11. Apfel S.C., Schwartz S., Adornato B.T., Freeman R., Biton V., Rendell M., Vinik A., Giuliani M., Stevens J.C., Barbano R., and Dyck P.J. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 284 (2000) 2215-2221
12. Baek S.Y., and Kim S.U. Proliferation of human Schwann cells induced by neu differentiation factor isoforms. Dev. Neurosci. 20 (1998) 512-517
13. Bagossi P., Horvath G., Vereb G., Szollosi J., and Tozser J. Molecular modeling of nearly full-length ErbB2 receptor. Biophys. J. 88 (2005) 1354-1363
14. Bao J., Wolpowitz D., Role L.W., and Talmage D.A. Back signaling by the Nrg-1 intracellular domain. J. Cell Biol. 161 (2003) 1133-1141
15. Barnett S.C., and Riddell J.S. Olfactory ensheathing cells (OECs) and the treatment of CNS injury: advantages and possible caveats. J. Anat. 204 (2004) 57-67
16. Barnett S.C., Alexander C.L., Iwashita Y., Gilson J.M., Crowther J., Clark L., Dunn L.T., Papanastassiou V., Kennedy P.G., and Franklin R.J. Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons. Brain 123 Pt 8 (2000) 1581-1588
17. Bennett D.L., Michael G.J., Ramachandran N., Munson J.B., Averill S., Yan Q., McMahon S.B., and Priestley J.V. A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J. Neurosci. 18 (1998) 3059-3072
18. Boruch A.V., Conners J.J., Pipitone M., Deadwyler G., Storer P.D., Devries G.H., and Jones K.J. Neurotrophic and migratory properties of an olfactory ensheathing cell line. Glia 33 (2001) 225-229
19. Boulton A.J., and Malik R.A. Diabetic neuropathy. Med. Clin. North Am. 82 (1998) 909-929
20. Boyd J.G., and Gordon T. Glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor sustain the axonal regeneration of chronically axotomized motoneurons in vivo. Exp. Neurol. 183 (2003) 610-619
21. Bray G.M., Villegas-Perez M.P., Vidal-Sanz M., Carter D.A., and Aguayo A.J. Neuronal and nonneuronal influences on retinal ganglion cell survival, axonal regrowth, and connectivity after axotomy. Ann. N. Y. Acad. Sci. 633 (1991) 214-228
22. Brown A., Ricci M.J., and Weaver L.C. NGF message and protein distribution in the injured rat spinal cord. Exp. Neurol. 188 (2004) 115-127
23. Bunge M.B., and Pearse D.D. Transplantation strategies to promote repair of the injured spinal cord. J. Rehabil. Res. Dev. 40 (2003) 55-62
24. Buonanno A., and Fischbach G.D. Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr. Opin. Neurobiol. 11 (2001) 287-296
25. Cabedo H., Luna C., Fernandez A.M., Gallar J., and Ferrer-Montiel A. Molecular determinants of the sensory and motor neuron-derived factor insertion into plasma membrane. J. Biol. Chem. 277 (2002) 19905-19912
26. Calaora V., Rogister B., Bismuth K., Murray K., Brandt H., Leprince P., Marchionni M., and Dubois-Dalcq M. Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro. J. Neurosci. 21 (2001) 4740-4751
27. Cannella B., Hoban C.J., Gao Y.L., Garcia-Arenas R., Lawson D., Marchionni M., Gwynne D., and Raine C.S. The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10100-10105
28. Cannella B., Pitt D., Marchionni M., and Raine C.S. Neuregulin and erbB receptor expression in normal and diseased human white matter. J. Neuroimmunol. 100 (1999) 233-242
29. Canoll P.D., Musacchio J.M., Hardy R., Reynolds R., Marchionni M.A., and Salzer J.L. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 17 (1996) 229-243
30. Canoll P.D., Kraemer R., Teng K.K., Marchionni M.A., and Salzer J.L. GGF/neuregulin induces a phenotypic reversion of oligodendrocytes. Mol. Cell. Neurosci. 13 (1999) 79-94
31. Cao L., Liu L., Chen Z.Y., Wang L.M., Ye J.L., Qiu H.Y., Lu C.L., and He C. Olfactory ensheathing cells genetically modified to secrete GDNF to promote spinal cord repair. Brain 127 (2004) 535-549
32. Carlsson M., and Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-Implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13 (1990) 272-276
33. Carraway III K.L., Weber J.L., Unger M.J., Ledesma J., Yu N., Gassmann M., and Lai C. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature 387 (1997) 512-516
34. Carroll S.L., Miller M.L., Frohnert P.W., Kim S.S., and Corbett J.A. Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration. J. Neurosci. 17 (1997) 1642-1659
35. Chan J.R., Cosgaya J.M., Wu Y.J., and Shooter E.M. Neurotrophins are key mediators of the myelination program in the peripheral nervous system. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 14661-14668
36. Chang H., Riese II D.J., Gilbert W., Stern D.F., and McMahan U.J. Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature 387 (1997) 509-512
37. Chen S., Rio C., Ji R.R., Dikkes P., Coggeshall R.E., Woolf C.J., and Corfas G. Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss. Nat. Neurosci. 6 (2003) 1186-1193
38. Cho H.J., Kim J.K., Park H.C., Kim D.S., Ha S.O., and Hong H.S. Changes in brain-derived neurotrophic factor immunoreactivity in rat dorsal root ganglia, spinal cord, and gracile nuclei following cut or crush injuries. Exp. Neurol. 154 (1998) 224-230
39. Ciutat D., Caldero J., Oppenheim R.W., and Esquerda J.E. Schwann cell apoptosis during normal development and after axonal degeneration induced by neurotoxins in the chick embryo. J. Neurosci. 16 (1996) 3979-3990
40. Colognato H., Baron W., Avellana-Adalid V., Relvas J.B., Baron-Van Evercooren A., Georges-Labouesse E., and ffrench-Constant C. CNS integrins switch growth factor signalling to promote target-dependent survival. Nat. Cell Biol. 4 (2002) 833-841
41. Colognato H., Ramachandrappa S., Olsen I.M., and ffrench-Constant C. Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J. Cell Biol. 167 (2004) 365-375
42. Corfas G., Falls D.L., and Fischbach G.D. ARIA, a protein that stimulates acetylcholine receptor synthesis, also induces tyrosine phosphorylation of a 185-kDa muscle transmembrane protein. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 1624-1628
43. Corfas G., Rosen K.M., Aratake H., Krauss R., and Fischbach G.D. Differential expression of ARIA isoforms in the rat brain. Neuron 14 (1995) 103-115
44. Corfas G., Roy K., and Buxbaum J.D. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat. Neurosci. 7 (2004) 575-580
45. Cosgaya J.M., Chan J.R., and Shooter E.M. The neurotrophin receptor p75NTR as a positive modulator of myelination. Science 298 (2002) 1245-1248
46. Deadwyler G.D., Pouly S., Antel J.P., and Devries G.H. Neuregulins and erbB receptor expression in adult human oligodendrocytes. Glia 32 (2000) 304-312
47. Di Trapani G., Barone C., La Cara A., and Laurienzo P. Dementia-peripheral neuropathy during combined deficiency of vitamin B12 and folate. Light microscopy and ultrastructural study of sural nerve. Ital. J. Neurol. Sci. 7 (1986) 545-552
48. Dobrowsky R.T., Rouen S., and Yu C. Altered neurotrophism in diabetic neuropathy: spelunking the caves of peripheral nerve. J. Pharmacol. Exp. Ther. (2004) 485-491
49. Dong Z., Brennan A., Liu N., Yarden Y., Lefkowitz G., Mirsky R., and Jessen K.R. Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors. Neuron 15 (1995) 585-596
50. Eckersley L. Role of the Schwann cell in diabetic neuropathy. Int. Rev. Neurobiol. 50 (2002) 293-321
51. Escher P., Lacazette E., Courtet M., Blindenbacher A., Landmann L., Bezakova G., Lloyd K.C., Mueller U., and Brenner H.R. Synapses form in skeletal muscles lacking neuregulin receptors. Science 308 (2005) 1920-1923
52. Esper R.M., and Loeb J.A. Rapid axoglial signaling mediated by neuregulin and neurotrophic factors. J. Neurosci. 24 (2004) 6218-6227
53. Facer P., Mann D., Mathur R., Pandya S., Ladiwala U., Singhal B., Hongo J., Sinicropi D.V., Terenghi G., and Anand P. Do nerve growth factor-related mechanisms contribute to loss of cutaneous nociception in leprosy?. Pain 85 (2000) 231-238
54. Falls D.L. Neuregulins: functions, forms, and signaling strategies. Exp. Cell Res. 284 (2003) 14-30
55. Falls D.L., Harris D.A., Johnson F.A., Morgan M.M., Corfas G., and Fischbach G.D. Mr 42,000 ARIA: a protein that may regulate the accumulation of acetylcholine receptors at developing chick neuromuscular junctions. Cold Spring Harbor Symp. Quant. Biol. 55 (1990) 397-406
56. Falls D.L., Rosen K.M., Corfas G., Lane W.S., and Fischbach G.D. ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell 72 (1993) 801-815
57. Fan X., and Gelman B.B. Schwann cell nerve growth factor receptor expression during initiation of remyelination. J. Neurosci. Res. 31 (1992) 58-67
58. Ferguson K.M. Active and inactive conformations of the epidermal growth factor receptor. Biochem. Soc. Trans. 32 (2004) 742-745
59. Fischbach G.D., and Rosen K.M. ARIA: a neuromuscular junction neuregulin. Annu. Rev. Neurosci. 20 (1997) 429-458
60. Flames N., Long J.E., Garratt A.N., Fischer T.M., Gassmann M., Birchmeier C., Lai C., Rubenstein J.L., and Marin O. Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron 44 (2004) 251-261
61. Franklin R.J. Why does remyelination fail in multiple sclerosis?. Nat. Rev., Neurosci. 3 (2002) 705-714
62. Funakoshi H., Frisen J., Barbany G., Timmusk T., Zachrisson O., Verge V.M., and Persson H. Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J. Cell Biol. 123 (1993) 455-465
63. Garcia R.A., Vasudevan K., and Buonanno A. The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3596-3601
64. Garcia-Alias G., Lopez-Vales R., Fores J., Navarro X., and Verdu E. Acute transplantation of olfactory ensheathing cells or Schwann cells promotes recovery after spinal cord injury in the rat. J. Neurosci. Res. 75 (2004) 632-641
65. Garratt A.N., Voiculescu O., Topilko P., Charnay P., and Birchmeier C. A dual role of erbB2 in myelination and in expansion of the Schwann cell precursor pool. J. Cell Biol. 148 (2000) 1035-1046
66. Gassmann M., Casagranda F., Orioli D., Simon H., Lai C., Klein R., and Lemke G. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378 (1995) 390-394
67. Gerecke K.M., Wyss J.M., Karavanova I., Buonanno A., and Carroll S.L. ErbB transmembrane tyrosine kinase receptors are differentially expressed throughout the adult rat central nervous system. J. Comp. Neurol. 433 (2001) 86-100
68. Gerecke K.M., Wyss J.M., and Carroll S.L. Neuregulin-1beta induces neurite extension and arborization in cultured hippocampal neurons. Mol. Cell. Neurosci. 27 (2004) 379-393
69. Gilmour L.M., Macleod K.G., McCaig A., Sewell J.M., Gullick W.J., Smyth J.F., and Langdon S.P. Neuregulin expression, function, and signaling in human ovarian cancer cells. Clin. Cancer Res. 8 (2002) 3933-3942
70. Golub M.S., Germann S.L., and Lloyd K.C. Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse. Behav. Brain Res. 153 (2004) 159-170
71. Goodearl A.D., Yee A.G., Sandrock Jr. A.W., Corfas G., and Fischbach G.D. ARIA is concentrated in the synaptic basal lamina of the developing chick neuromuscular junction. J. Cell Biol. 130 (1995) 1423-1434
72. Grinspan J.B., Marchionni M.A., Reeves M., Coulaloglou M., and Scherer S.S. Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J. Neurosci. 16 (1996) 6107-6118
73. Gu Z., Jiang Q., Fu A.K.Y., Ip N.Y., and Yan Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J. Neurosci. 25 (2005) 4974-4984
74. Hansen M.R., and Linthicum Jr. F.H. Expression of neuregulin and activation of erbB receptors in vestibular schwannomas: possible autocrine loop stimulation. Otol. Neurotol. 25 (2004) 155-159
75. Harari D., Tzahar E., Romano J., Shelly M., Pierce J.H., Andrews G.C., and Yarden Y. Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase. Oncogene 18 (1999) 2681-2689
76. Hayashi M., Ueyama T., Nemoto K., Tamaki T., and Senba E. Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J. Neurotrauma 17 (2000) 203-218
77. Ho W.H., Armanini M.P., Nuijens A., Phillips H.S., and Osheroff P.L. Sensory and motor neuron-derived factor. A novel heregulin variant highly expressed in sensory and motor neurons. J. Biol. Chem. 270 (1995) 26722
78. Hobbs S.S., Coffing S.L., Le A.T., Cameron E.M., Williams E.E., Andrew M., Blommel E.N., Hammer R.P., Chang H., and Riese D.J. Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation. Oncogene 21 (2002) 8442-8452
79. Hoke A., Ho T., Crawford T.O., LeBel C., Hilt D., and Griffin J.W. Glial cell line-derived neurotrophic factor alters axon Schwann cell units and promotes myelination in unmyelinated nerve fibers. J. Neurosci. 23 (2003) 561-567
80. Holbro T., and Hynes N.E. ErbB receptors: directing key signaling networks throughout life. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 195-217
81. Holmes W.E., Sliwkowski M.X., Akita R.W., Henzel W.J., Lee J., Park J.W., Yansura D., Abadi N., Raab H., Lewis G.D., et al. Identification of heregulin, a specific activator of p185erbB2. Science 256 (1992) 1205-1210
82. Houenou L.J., Oppenheim R.W., Li L., Lo A.C., and Prevette D. Regulation of spinal motoneuron survival by GDNF during development and following injury. Cell Tissue Res. 286 (1996) 219-223
83. Huang Y.Z., Won S., Ali D.W., Wang Q., Tanowitz M., Du Q.S., Pelkey K.A., Yang D.J., Xiong W.C., Salter M.W., and Mei L. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 26 (2000) 443-455
84. Huijbregts R.P., Roth K.A., Schmidt R.E., and Carroll S.L. Hypertrophic neuropathies and malignant peripheral nerve sheath tumors in transgenic mice overexpressing glial growth factor beta3 in myelinating Schwann cells. J. Neurosci. 23 (2003) 7269-7280
85. Ishiguro H., Higashiyama S., Yamada K., Ichino N., Taniguchi N., and Nagatsu T. Structure and function of a novel ErbB ligand, NTAK. Nihon Shinkei Seishin Yakurigaku Zasshi 18 (1998) 137-142
86. Jessen K.R., and Mirsky R. Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci. 22 (1999) 402-410
87. Jessen K.R., and Mirsky R. Signals that determine Schwann cell identity. J. Anat. 200 (2002) 367-376
88. Jo S.A., Zhu X., Marchionni M.A., and Burden S.J. Neuregulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression. Nature 373 (1995) 158-161
89. John G.R., Shankar S.L., Shafit-Zagardo B., Massimi A., Lee S.C., Raine C.S., and Brosnan C.F. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. 8 (2002) 1115-1121
90. Kato T., Honmou O., Uede T., Hashi K., and Kocsis J.D. Transplantation of human olfactory ensheathing cells elicits remyelination of demyelinated rat spinal cord. Glia 30 (2000) 209-218
91. Kerber G., Streif R., Schwaiger F.W., Kreutzberg G.W., and Hager G. Neuregulin-1 isoforms are differentially expressed in the intact and regenerating adult rat nervous system. J. Mol. Neurosci. 21 (2003) 149-165
92. Kim J.Y., Sun Q., Oglesbee M., and Yoon S.O. The role of ErbB2 signaling in the onset of terminal differentiation of oligodendrocytes in vivo. J. Neurosci. 23 (2003) 5561-5571
93. Lai C., and Feng L. Neuregulin induces proliferation of neural progenitor cells via PLC/PKC pathway. Biochem. Biophys. Res Commun. 319 (2004) 603-611
94. Lakatos A., Barnett S.C., and Franklin R.J. Olfactory ensheathing cells induce less host astrocyte response and chondroitin sulphate proteoglycan expression than Schwann cells following transplantation into adult CNS white matter. Exp. Neurol. 184 (2003) 237-246
95. Law A.J., Shannon Weickert C., Hyde T.M., Kleinman J.E., and Harrison P.J. Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain. Neuroscience 127 (2004) 125-136
96. Lee K.F., Simon H., Chen H., Bates B., Hung M.C., and Hauser C. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378 (1995) 394-398
97. Levi A., Bunge R., Lofgren J., Meima L., Hefti F., Nikolics K., and Sliwkowski M. The influence of heregulins on human Schwann cell proliferation. J. Neurosci. 15 (1995) 1329-1340
98. Li Q., and Loeb J.A. Neuregulin-heparan-sulfate proteoglycan interactions produce sustained erbB receptor activation required for the induction of acetylcholine receptors in muscle. J. Biol. Chem. 276 (2001) 38068-38075
99. Li H., Terenghi G., and Hall S.M. Effects of delayed re-innervation on the expression of c-erbB receptors by chronically denervated rat Schwann cells in vivo. Glia 20 (1997) 333-347
100. Li Q., Esper R.M., and Loeb J.A. Synergistic effects of neuregulin and agrin on muscle acetylcholine receptor expression. Mol. Cell. Neurosci. 26 (2004) 558-569
101. Li T., Stefansson H., Gudfinnsson E., Cai G., Liu X., Murray R.M., Steinthorsdottir V., Januel D., Gudnadottir V.G., Petursson H., Ingason A., Gulcher J.R., Stefansson K., and Collier D.A. Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype. Mol. Psychiatry 9 (2004) 698-704
102. Lindholm T., Cullheim S., Deckner M., Carlstedt T., and Risling M. Expression of neuregulin and ErbB3 and ErbB4 after a traumatic lesion in the ventral funiculus of the spinal cord and in the intact primary olfactory system. Exp. Brain Res. 142 (2002) 81-90
103. Liu Y., Ford B., Mann M.A., and Fischbach G.D. Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus. J. Neurosci. 21 (2001) 5660-5669
104. Loeb J.A. Neuregulin: An activity-dependent synaptic modulator at the neuromuscular junction. J. Neurocytol. 32 (2003) 649-664
105. Loeb J.A., and Fischbach G.D. ARIA can be released from extracellular matrix through cleavage of a heparin-binding domain. J. Cell Biol. 130 (1995) 127-135
106. Loeb J.A., and Fischbach G.D. Neurotrophic factors increase neuregulin expression in embryonic ventral spinal cord neurons. J. Neurosci. 17 (1997) 1416-1424
107. Loeb J.A., Khurana T.S., Robbins J.T., Yee A.G., and Fischbach G.D. Expression patterns of transmembrane and released forms of neuregulin during spinal cord and neuromuscular synapse development. Development 126 (1999) 781-791
108. Loeb J.A., Hmadcha A., Fischbach G.D., Land S.J., and Zakarian V.L. Neuregulin expression at neuromuscular synapses is modulated by synaptic activity and neurotrophic factors. J. Neurosci. 22 (2002) 2206-2214
109. Marchionni M.A., Goodearl A.D., Chen M.S., Bermingham-McDonogh O., Kirk C., Hendricks M., Danehy F., Misumi D., Sudhalter J., Kobayashi K., et al. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 362 (1993) 312-318
110. Marchionni M.A., Cannella B., Hoban C., Gao Y.L., Garcia-Arenas R., Lawson D., Happel E., Noel F., Tofilon P., Gwynne D., and Raine C.S. Neuregulin in neuron/glial interactions in the central nervous system. GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination. Adv. Exp. Med. Biol. 468 (1999) 283-295
111. Martin C., Solders G., Sonnerborg A., and Hansson P. Painful and non-painful neuropathy in HIV-infected patients: an analysis of somatosensory nerve function. Eur. J. Pain 7 (2003) 23-31
112. McArthur, J.C., 1996. Dementia, neuropathy, and HIV. An interview with Justin C. McArthur, MB, BS, MPH. Interview by Mark Mascolini, J. Int. Assoc. Physicians AIDS Care 2, 27-28, 31-24.
113. McCarron M.O., Russell A.J., Metcalfe R.A., and Deysilva R. Chronic vitamin E deficiency causing spinocerebellar degeneration, peripheral neuropathy, and centro-cecal scotomata. Nutrition 15 (1999) 217-219
114. Meier T., Masciulli F., Moore C., Schoumacher F., Eppenberger U., Denzer A.J., Jones G., and Brenner H.R. Agrin can mediate acetylcholine receptor gene expression in muscle by aggregation of muscle-derived neuregulins. J. Cell Biol. 141 (1998) 715-726
115. Meyer D., and Birchmeier C. Multiple essential functions of neuregulin in development. Nature 378 (1995) 386-390
116. Michailov G.V., Sereda M.W., Brinkmann B.G., Fischer T.M., Haug B., Birchmeier C., Role L., Lai C., Schwab M.H., and Nave K.A. Axonal neuregulin-1 regulates myelin sheath thickness. Science 304 (2004) 700-703
117. Mirsky R., Stewart H.J., Tabernero A., Bradke F., Brennan A., Dong Z., and Jessen K.R. Development and differentiation of Schwann cells. Rev. Neurol. (Paris) 152 (1996) 308-313
118. Mirsky R., Jessen K.R., Brennan A., Parkinson D., Dong Z., Meier C., Parmantier E., and Lawson D. Schwann cells as regulators of nerve development. J. Physiol. Paris 96 (2002) 17-24
119. Mohn A.R., Gainetdinov R.R., Caron M.G., and Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98 (1999) 427-436
120. Moreno-Flores M.T., Diaz-Nido J., Wandosell F., and Avila J. Olfactory ensheathing glia: drivers of axonal regeneration in the central nervous system?. J. Biomed. Biotechnol. 2 (2002) 37-43
121. Morris J.K., Lin W., Hauser C., Marchuk Y., Getman D., and Lee K.F. Rescue of the cardiac defect in ErbB2 mutant mice reveals essential roles of ErbB2 in peripheral nervous system development. Neuron 23 (1999) 273-283
122. Morrissey T.K., Kleitman N., and Bunge R.P. Human Schwann cells in vitro. II. Myelination of sensory axons following extensive purification and heregulin-induced expansion. J. Neurobiol. 28 (1995) 190-201
123. Morrissey T.K., Levi A.D., Nuijens A., Sliwkowski M.X., and Bunge R.P. Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 1431-1435
124. Moscoso L.M., Chu G.C., Gautam M., Noakes P.G., Merlie J.P., and Sanes J.R. Synapse-associated expression of an acetylcholine receptor-inducing protein, ARIA/heregulin, and its putative receptors, ErbB2 and ErbB3, in developing mammalian muscle. Dev. Biol. 172 (1995) 158-169
125. Munson J.B., and McMahon S.B. Effects of GDNF on axotomized sensory and motor neurons in adult rats. Eur. J. Neurosci. 9 (1997) 1126-1129
126. Munson J.B., Shelton D.L., and McMahon S.B. Adult mammalian sensory and motor neurons: roles of endogenous neurotrophins and rescue by exogenous neurotrophins after axotomy. J. Neurosci. 17 (1997) 470-476
127. Murakami Y., Furukawa S., Nitta A., and Furukawa Y. Accumulation of nerve growth factor protein at both rostral and caudal stumps in the transected rat spinal cord. J. Neurol. Sci. 198 (2002) 63-69
128. Nakamura M., and Bregman B.S. Differences in neurotrophic factor gene expression profiles between neonate and adult rat spinal cord after injury. Exp. Neurol. 169 (2001) 407-415
129. Nations S.P., and Barohn R.J. Peripheral neuropathy due to leprosy. Curr. Treat. Options Neurol. 4 (2002) 189-196
130. Negro A., Brar B.K., and Lee K.F. Essential roles of Her2/erbB2 in cardiac development and function. Recent Prog. Horm. Res. 59 (2004) 1-12
131. Nogami K., Suzuki H., Habuchi H., Ishiguro N., Iwata H., and Kimata K. Distinctive expression patterns of heparan sulfate O-sulfotransferases and regional differences in heparan sulfate structure in chick limb buds. J. Biol. Chem. 279 (2004) 8219-8229
132. Novak K.D., Prevette D., Wang S., Gould T.W., and Oppenheim R.W. Hepatocyte growth factor/scatter factor is a neurotrophic survival factor for lumbar but not for other somatic motoneurons in the chick embryo. J. Neurosci. 20 (2000) 326-337
133. Oka N., Kawasaki T., Matsui M., Tachibana H., Sugita M., and Akiguchi I. Neuregulin is associated with nerve regeneration in axonal neuropathies. NeuroReport 11 (2000) 3673-3676
134. Oppenheim R.W., Houenou L.J., Parsadanian A.S., Prevette D., Snider W.D., and Shen L. Glial cell line-derived neurotrophic factor and developing mammalian motoneurons: regulation of programmed cell death among motoneuron subtypes. J. Neurosci. 20 (2000) 5001-5011
135. Oudega M., and Hagg T. Neurotrophins promote regeneration of sensory axons in the adult rat spinal cord. Brain Res. 818 (1999) 431-438
136. Ozaki M., Sasner M., Yano R., Lu H.S., and Buonanno A. Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 390 (1997) 691-694
137. Pankonin M.S., Gallagher J.T., and Loeb J.A. Specific structural features of heparan sulfate proteoglycans potentiate neuregulin-1 signaling. J. Biol. Chem. 280 (2005) 383-388
138. Park S.K., Miller R., Krane I., and Vartanian T. The erbB2 gene is required for the development of terminally differentiated spinal cord oligodendrocytes. J. Cell Biol. 154 (2001) 1245-1258
139. Park S.K., Solomon D., and Vartanian T. Growth factor control of CNS myelination. Dev. Neurosci. 23 (2001) 327-337
140. Parker M.W., Chen Y., Hallenbeck J.M., and Ford B.D. Neuregulin expression after focal stroke in the rat. Neurosci. Lett. 334 (2002) 169-172
141. Pellegrino R.G., Politis M.J., Ritchie J.M., and Spencer P.S. Events in degenerating cat peripheral nerve: induction of Schwann cell S phase and its relation to nerve fibre degeneration. J. Neurocytol. 15 (1986) 17-28
142. Penderis J., Woodruff R.H., Lakatos A., Li W.W., Dunning M.D., Zhao C., Marchionni M., and Franklin R.J. Increasing local levels of neuregulin (glial growth factor-2) by direct infusion into areas of demyelination does not alter remyelination in the rat CNS. Eur. J. Neurosci. 18 (2003) 2253-2264
143. Pinkas-Kramarski R., Eilam R., Spiegler O., Lavi S., Liu N., Chang D., Wen D., Schwartz M., and Yarden Y. Brain neurons and glial cells express Neu differentiation factor/heregulin: a survival factor for astrocytes. Proc. Natl Acad. Sci. U. S. A. 91 (1994) 9387-9391
144. Pinkas-Kramarski R., Shelly M., Glathe S., Ratzkin B.J., and Yarden Y. Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations. J. Biol. Chem. 271 (1996) 19029-19032
145. Pinkas-Kramarski R., Soussan L., Waterman H., Levkowitz G., Alroy I., Klapper L., Lavi S., Seger R., Ratzkin B.J., Sela M., and Yarden Y. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J. 15 (1996) 2452-2467
146. Pinkas-Kramarski R., Eilam R., Alroy I., Levkowitz G., Lonai P., and Yarden Y. Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation. Oncogene 15 (1997) 2803-2815
147. Pittenger G., and Vinik A. Nerve growth factor and diabetic neuropathy. Exp. Diabesity Res. 4 (2003) 271-285
148. Raabe T.D., Deadwyler G., Varga J.W., and Devries G.H. Localization of neuregulin isoforms and erbB receptors in myelinating glial cells. Glia 45 (2004) 197-207
149. Raisman G. Olfactory ensheathing cells-Another miracle cure for spinal cord injury?. Nat. Rev., Neurosci. 2 (2001) 369-375
150. Resnick D.K., Cechvala C.F., Yan Y., Witwer B.P., Sun D., and Zhang S. Adult olfactory ensheathing cell transplantation for acute spinal cord injury. J. Neurotrauma 20 (2003) 279-285
151. Richardson P.M., McGuinness U.M., and Aguayo A.J. Axons from CNS neurons regenerate into PNS grafts. Nature 284 (1980) 264-265
152. Rieff H.I., Raetzman L.T., Sapp D.W., Yeh H.H., Siegel R.E., and Corfas G. Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells. J. Neurosci. 19 (1999) 10757-10766
153. Riese II D.J., van Raaij T.M., Plowman G.D., Andrews G.C., and Stern D.F. The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol. Cell. Biol. 15 (1995) 5770-5776
154. Riese II D.J., and Stern D.F. Specificity within the EGF family/ErbB receptor family signaling network. BioEssays 20 (1998) 41-48
155. Riethmacher D., Sonnenberg-Riethmacher E., Brinkmann V., Yamaai T., Lewin G.R., and Birchmeier C. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature 389 (1997) 725-730
156. Rio C., Rieff H.I., Qi P., Khurana T.S., and Corfas G. Neuregulin and erbB receptors play a critical role in neuronal migration. Neuron 19 (1997) 39-50
157. Risling M., Fried K., Linda H., Carlstedt T., and Cullheim S. Regrowth of motor axons following spinal cord lesions: distribution of laminin and collagen in the CNS scar tissue. Brain Res. Bull. 30 (1993) 405-414
158. Sandrock Jr. A.W., Dryer S.E., Rosen K.M., Gozani S.N., Kramer R., Theill L.E., and Fischbach G.D. Maintenance of acetylcholine receptor number by neuregulins at the neuromuscular junction in vivo. Science 276 (1997) 599-603
159. Sanes J.R., and Lichtman J.W. Development of the vertebrate neuromuscular junction. Annu. Rev. Neurosci. 22 (1999) 389-442
160. Sapru M.K., Florance S.K., Kirk C., and Goldman D. Identification of a neuregulin and protein-tyrosine phosphatase response element in the nicotinic acetylcholine receptor epsilon subunit gene: regulatory role of an Rts transcription factor. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 1289-1294
161. Sayer F.T., Oudega M., and Hagg T. Neurotrophins reduce degeneration of injured ascending sensory and corticospinal motor axons in adult rat spinal cord. Exp. Neurol. 175 (2002) 282-296
162. Scherer S.S. The biology and pathobiology of Schwann cells. Curr. Opin. Neurol. 10 (1997) 386-397
163. Schifitto G., Yiannoutsos C., Simpson D.M., Adornato B.T., Singer E.J., Hollander H., Marra C.M., Rubin M., Cohen B.A., Tucker T., Koralnik I.J., Katzenstein D., Haidich B., Smith M.E., Shriver S., Millar L., Clifford D.B., and McArthur J.C. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology 57 (2001) 1313-1316
164. Schmid R.S., McGrath B., Berechid B.E., Boyles B., Marchionni M., Sestan N., and Anton E.S. Neuregulin 1-erbB2 signaling is required for the establishment of radial glia and their transformation into astrocytes in cerebral cortex. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 4251-4256
165. Schnell L., Schneider R., Kolbeck R., Barde Y.A., and Schwab M.E. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature 367 (1994) 170-173
166. Schroering A., and Carey D.J. Sensory and motor neuron-derived factor is a transmembrane heregulin that is expressed on the plasma membrane with the active domain exposed to the extracellular environment. J. Biol. Chem. 273 (1998) 30643-30650
167. Sebert M.E., and Shooter E.M. Expression of mRNA for neurotrophic factors and their receptors in the rat dorsal root ganglion and sciatic nerve following nerve injury. J. Neurosci. Res. 36 (1993) 357-367
168. Sendtner M., Kreutzberg G.W., and Thoenen H. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345 (1990) 440-441
169. Shyu W.C., Lin S.Z., Chiang M.F., Yang H.I., Thajeb P., and Li H. Neuregulin-1 reduces ischemia-induced brain damage in rats. Neurobiol. Aging 25 (2004) 935-944
170. Smith P.M., Sim F.J., Barnett S.C., and Franklin R.J. SCIP/Oct-6, Krox-20, and desert hedgehog mRNA expression during CNS remyelination by transplanted olfactory ensheathing cells. Glia 36 (2001) 342-353
171. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H., and Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71 (2002) 877-892
172. Stefansson H., Sarginson J., Kong A., Yates P., Steinthorsdottir V., Gudfinnsson E., Gunnarsdottir S., Walker N., Petursson H., Crombie C., Ingason A., Gulcher J.R., Stefansson K., and St Clair D. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am. J. Hum. Genet. 72 (2003) 83-87
173. Steiner I., Kidron D., Soffer D., Wirguin I., and Abramsky O. Sensory peripheral neuropathy of vitamin B12 deficiency: a primary demyelinating disease?. J. Neurol. 235 (1988) 163-164
174. Steinthorsdottir V., Stefansson H., Ghosh S., Birgisdottir B., Bjornsdottir S., Fasquel A.C., Olafsson O., Stefansson K., and Gulcher J.R. Multiple novel transcription initiation sites for NRG1. Gene 342 (2004) 97-105
175. Stoll G., Griffin J.W., Li C.Y., and Trapp B.D. Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J. Neurocytol. 18 (1989) 671-683
176. Sussman C.R., Dyer K.L., Marchionni M., and Miller R.H. Local control of oligodendrocyte development in isolated dorsal mouse spinal cord. J. Neurosci. Res. 59 (2000) 413-420
177. Syroid D.E., Maycox P.R., Burrola P.G., Liu N., Wen D., Lee K.F., Lemke G., and Kilpatrick T.J. Cell death in the Schwann cell lineage and its regulation by neuregulin. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9229-9234
178. Takahashi A., Mizutani M., and Itakura C. Acrylamide-induced peripheral neuropathy in normal and neurofilament-deficient Japanese quails. Acta Neuropathol. (Berl.) 89 (1995) 17-22
179. ter Laak M.P., Hamers F.P., Kirk C.J., and Gispen W.H. rhGGF2 protects against cisplatin-induced neuropathy in the rat. J. Neurosci. Res. 60 (2000) 237-244
180. Thompson R.J., Roberts B., Alexander C.L., Williams S.K., and Barnett S.C. Comparison of neuregulin-1 expression in olfactory ensheathing cells, Schwann cells and astrocytes. J. Neurosci. Res. 61 (2000) 172-185
181. Tobias C.A., Shumsky J.S., Shibata M., Tuszynski M.H., Fischer I., Tessler A., and Murray M. Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration. Exp. Neurol. .184 (2003) 97-113
182. Tokita Y., Keino H., Matsui F., Aono S., Ishiguro H., Higashiyama S., and Oohira A. Regulation of neuregulin expression in the injured rat brain and cultured astrocytes. J. Neurosci. 21 (2001) 1257-1264
183. Topilko P., Murphy P., and Charnay P. Embryonic development of Schwann cells: multiple roles for neuregulins along the pathway. Mol. Cell. Neurosci. 8 (1996) 71-75
184. Trachtenberg J.T., and Thompson W.J. Schwann cell apoptosis at developing neuromuscular junctions is regulated by glial growth factor. Nature 379 (1996) 174-177
185. Valensi P., Giroux C., Seeboth-Ghalayini B., and Attali J.R. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors. J. Diabetes Its Complicat. 11 (1997) 27-34
186. Vartanian T., Goodearl A., Viehover A., and Fischbach G. Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3. J. Cell Biol. 137 (1997) 211-220
187. Vartanian T., Fischbach G., and Miller R. Failure of spinal cord oligodendrocyte development in mice lacking neuregulin. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 731-735
188. Verge V.M., Gratto K.A., Karchewski L.A., and Richardson P.M. Neurotrophins and nerve injury in the adult. Philos. Trans. R. Soc. Lond., B Biol. Sci. 351 (1996) 423-430
189. Viehover A., Miller R.H., Park S.K., Fischbach G., and Vartanian T. Neuregulin: an oligodendrocyte growth factor absent in active multiple sclerosis lesions. Dev. Neurosci. 23 (2001) 377-386
190. Vischer H.A. BDNF is expressed at the crush site after spinal cord lesion in newborn opossum (Monodelphis domestica). Eur. J. Neurosci. 9 (1997) 1993-1997
191. Wang J.Y., Miller S.J., and Falls D.L. The N-terminal region of neuregulin isoforms determines the accumulation of cell surface and released neuregulin ectodomain. J. Biol. Chem. 276 (2001) 2841-2851
192. Wen D., Peles E., Cupples R., Suggs S.V., Bacus S.S., Luo Y., Trail G., Hu S., Silbiger S.M., Levy R.B., et al. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell 69 (1992) 559-572
193. Wen D., Suggs S.V., Karunagaran D., Liu N., Cupples R.L., Luo Y., Janssen A.M., Ben-Baruch N., Trollinger D.B., Jacobsen V.L., et al. Structural and functional aspects of the multiplicity of Neu differentiation factors. Mol. Cell. Biol. 14 (1994) 1909-1919
194. Widenfalk J., Lundstromer K., Jubran M., Brene S., and Olson L. Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid. J. Neurosci. 21 (2001) 3457-3475
195. Williams S.K., Franklin R.J., and Barnett S.C. Response of olfactory ensheathing cells to the degeneration and regeneration of the peripheral olfactory system and the involvement of the neuregulins. J. Comp. Neurol. 470 (2004) 50-62
196. Winer J.B., Bang B., Clarke J.R., Knox K., Cook T.J., Gompels M., Hughes R.A., Hall S.M., Pinching A.J., Harris J.W., et al. A study of neuropathy in HIV infection. Q. J. Med. 83 (1992) 473-488
197. Winseck A.K., Caldero J., Ciutat D., Prevette D., Scott S.A., Wang G., Esquerda J.E., and Oppenheim R.W. In vivo analysis of Schwann cell programmed cell death in the embryonic chick: regulation by axons and glial growth factor. J. Neurosci. 22 (2002) 4509-4521
198. Woldeyesus M.T., Britsch S., Riethmacher D., Xu L., Sonnenberg-Riethmacher E., Abou-Rebyeh F., Harvey R., Caroni P., and Birchmeier C. Peripheral nervous system defects in erbB2 mutants following genetic rescue of heart development. Genes Dev. 13 (1999) 2538-2548
199. Woodhall E., West A.K., Vickers J.C., and Chuah M.I. Olfactory ensheathing cell phenotype following implantation in the lesioned spinal cord. Cell. Mol. Life Sci. 60 (2003) 2241-2253
200. Xie F., Raetzman L.T., and Siegel R.E. Neuregulin induces GABAA receptor beta2 subunit expression in cultured rat cerebellar granule neurons by activating multiple signaling pathways. J. Neurochem. 90 (2004) 1521-1529
201. Xu Z., Jiang J., Ford G., and Ford B.D. Neuregulin-1 is neuroprotective and attenuates inflammatory responses induced by ischemic stroke. Biochem. Biophys. Res. Commun. 322 (2004) 440-446
202. Yan D.H., Marin M.C., and Hung M.C. Differential expression of the neu oncogene in mouse liver and pancreatic cell lines. Biochem. Biophys. Res. Commun. 186 (1992) 363-370
203. Yan Q., Elliott J.L., Matheson C., Sun J., Zhang L., Mu X., Rex K.L., and Snider W.D. Influences of neurotrophins on mammalian motoneurons in vivo. J. Neurobiol. 24 (1993) 1555-1577
204. Yang X., Kuo Y., Devay P., Yu C., and Role L. A cysteine-rich isoform of neuregulin controls the level of expression of neuronal nicotinic receptor channels during synaptogenesis. Neuron 20 (1998) 255-270
205. Yasuda H., Terada M., Maeda K., Kogawa S., Sanada M., Haneda M., Kashiwagi A., and Kikkawa R. Diabetic neuropathy and nerve regeneration. Prog. Neurobiol. 69 (2003) 229-285
206. Zanazzi G., Einheber S., Westreich R., Hannocks M.J., Bedell-Hogan D., Marchionni M.A., and Salzer J.L. Glial growth factor/neuregulin inhibits Schwann cell myelination and induces demyelination. J. Cell Biol. 152 (2001) 1289-1299
207. Zhang D., Sliwkowski M.X., Mark M., Frantz G., Akita R., Sun Y., Hillan K., Crowley C., Brush J., and Godowski P.J. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9562-9567
208. Zhang J., Lineaweaver W.C., Oswald T., Chen Z., and Zhang F. Ciliary neurotrophic factor for acceleration of peripheral nerve regeneration: an experimental study. J. Reconstr. Microsurg. 20 (2004) 323-327
209. Zhao Y.Y., Sawyer D.R., Baliga R.R., Opel D.J., Han X., Marchionni M.A., and Kelly R.A. Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J. Biol. Chem. 273 (1998) 10261-10269
210. Zhu X., Lai C., Thomas S., and Burden S.J. Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses. EMBO J. 14 (1995) 5842-5848